Monthly Newsletter

Oxford Global’s marketing and sales campaign for The Biotherapeutics Series has brought about a record number of registration enquiries.

Senior level attendees from big pharma, smaller biotech companies and academic research institutions have already reserved their place across the 2 days, to contribute to high level scientific discussion with like minded peers.

Taking place on 20-21 April 2015 at The Novotel London West, the Bio-therapeutic Series consists of:

8th Annual Proteins & Antibodies Congress, 3rd Annual Biosimilars & Biobetters Congress and the 2nd Annual Peptides Congress 

This year there are also three post congress training seminars:

Antibody Engineering Seminar, Antibody Drug Conjugates Seminar, Peptides Seminar.

Over 350 senior level attendees will meet across the 2 days to exchange their experiences, engage in scientific discussions and network about the most pressing challenges of the industry. The seminars; limited to just 15 delegates are designed to be a highly interactive day of open discussion and practical advice. They are tailored to the individual - a pre seminar questionnaire will allow the trainer to design the day around individual needs of understanding specifics of the industry.

If you would like to know more about Europe’s leading congresses in Proteins, Biosimilars and Peptides and be part of this highly successful series, then contact Danielle Dalby today for a copy of the full conference programme. D.dalby@oxfordglobal.co.uk or call +44(0)1865 248455.

Places are now limited.